ClinicalTrials.Veeva

Menu

Exergaming to Increase Physical Activity in Overweight/Obese Children and Adolescents

N

Norwegian University of Science and Technology

Status

Terminated

Conditions

Obesity

Treatments

Behavioral: Exergaming

Study type

Interventional

Funder types

Other

Identifiers

NCT04122950
2019/1082

Details and patient eligibility

About

The primary purpose of this study is to examine the effects of regular exergaming for 8 weeks in 24 overweight/obese children and adolescents (10-17 years) on maximal aerobic fitness (VO2max) and physical activity levels measured before and after (8 weeks) intervention period, and in addition at follow-up (12 weeks). We also wish to investigate the effects on markers of cardio metabolic health and body composition, measured at baseline, 8 weeks and 12 weeks follow-up.

Also, the participants gaming frequency will be registered throughout the 8 week period, as well as during the follow-up between 8 and 12 weeks. Aim of this study is to investigate if access to this game can provide health benefits for overweight/obese children and adolescents.

Enrollment

6 patients

Sex

All

Ages

10 to 24 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Defined as overweight/obese for age and sex
  • Able to ride a bike for up to 60 minutes

Exclusion criteria

  • Known cardiovascular disease
  • Taking beta-blockers or anti-arrhythmic drugs
  • Other diseases that restrict them from doing High-Intensity Training

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

6 participants in 2 patient groups

Exergaming
Experimental group
Description:
The participants in the Exergaming group will use the PlayPulse exergame for 45 minutes a minimum of two times per week for 8 weeks. Between 8 and 12 weeks the exergaming group will be provided with free access to the exergame but without the two mandatory exergaming sessions
Treatment:
Behavioral: Exergaming
Control
No Intervention group
Description:
Continue with normal daily routine.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems